Sponsor & Developer Portfolio
Laure Pittet, MD-PhD
Clinical development pipeline, platform architecture, and registered trial tracking for Laure Pittet, MD-PhD vaccine candidates.
1
Candidates
1
Target Diseases
1
Linked Studies
Development Phase Distribution
Phase 3 Clinical Trial: 1
Platform Technologies
Biological (unspecified platform): 1
Target Pathogens & Indications
Measles / Mumps / Rubella
Vaccine Pipeline Candidates (1)
Detailed candidate profiles, clinical phases, target indications, and anticipated milestones.
Phase 3 Clinical Trial
ctgov-measles-mumps-rubella-vaccine-mmr-laure-pittet-md-phd
Measles-Mumps-Rubella vaccine (MMR)
Target: Measles / Mumps / Rubella
Platform: Biological (unspecified platform)
Key Milestone: Primary completion (most advanced trial): 2026-04 (registry estimate)
Explore Other Vaccine Developers & Sponsors
Compare pipeline volume, phase progression, and modalities across global biopharmaceutical manufacturers.